Less Ads, More Data, More Tools Register for FREE

Additional Listing

7 Oct 2014 09:45

RNS Number : 6325T
GW Pharmaceuticals PLC
07 October 2014
 



 

GW Pharmaceuticals PLC ("GW Pharmaceuticals")

 

ADDITIONAL LISTING

 

Porton Down, UK, 7 October 2014: GW Pharmaceuticals (AIM: GWP) hereby provides notification that application has today been made to the London Stock Exchange for admission to trading on AIM of 13,601 new ordinary shares of 0.1p each ("New Ordinary Shares").

The New Ordinary Shares are being issued pursuant to a subscription agreement connected to the acquisition of certain IP rights.

It is expected that such admission will become effective on 13 October 2014 and following admission to trading of the New Ordinary Shares 236,685,496 ordinary shares of 0.1 pence each will be in issue.

 

 

For further information, please contact:

 

GW Pharmaceuticals PLC +44 (0)1980 557 000

Adam George, Company Secretary

 

Peel Hunt LLP (Nominated Adviser)

James Steel/Oliver Jackson +44 (0) 20 7418 8900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISGIBDGDSGBGSR

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS